The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

Work +1 512 457 7000
Fax +1 512 457 7001

Karen Nelson

Work +1 512 457 7048
DLA Piper LLP (US)

Work Department

International Trade, Regulatory and Government Affairs; Administrative Law; Appellate Advocacy; Employment; Environment, Health and Safety; Employment Litigation and Dispute Resolution; Investigations; Litigation, Arbitration and Investigations; FDA; Healthcare; Government Contracting; Life Sciences


Partner; Chair, Healthcare Regulatory Enforcement and Compliance Practice


Karen Nelson focuses her practice on complex health care enforcement, compliance and regulatory matters.

Karen represents health industry clients concerning compliance with, and enforcement of, health industry laws and regulations—particularly in matters involving billing, audits and investigations, reimbursement,  conditions of participation, privacy, physician and referral source relationships, facility licensing, and transactional due diligence.


J.D., Baylor University School of Law; M.A., Southern Methodist University; B.A., Texas Tech University

United States: Industry focus

Healthcare: service providers

Within: Healthcare: service providers

The healthcare team at DLA Piper LLP (US) is 'strong in regulatory compliance and all kinds of transactional work', while also offering dispute resolution and data privacy advice. Miami-based practice lead Joshua Kaye, who delivers 'exceptional service, quality of work and attention to detail', assisted Somos Innovation on the establishment of a Medicaid-focused, value-based care system in New York together with Evolent, while well-regarded Philadelphia litigator Brian Benjet advised BioMatrix Specialty Pharmacy and its affiliates on a fraud claim from Highmark under the Racketeer Influenced and Corrupt Organizations Act. Austin partner Karen Nelson - who has 'deep experience and a practical approach' - successfully represented a hospital and health system in its attempt to prove non-compliance of external auditors with the procedural requirements during the client's audit investigation. Tom Califano, who is based in New York, specialises in representing healthcare companies in Chapter 11 proceedings.

[back to top]

Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to